266 related articles for article (PubMed ID: 32531395)
1. Recent progress of graphene oxide as a potential vaccine carrier and adjuvant.
Cao W; He L; Cao W; Huang X; Jia K; Dai J
Acta Biomater; 2020 Aug; 112():14-28. PubMed ID: 32531395
[TBL] [Abstract][Full Text] [Related]
2. Graphene oxide as novel vaccine adjuvant.
Vakili B; Karami-Darehnaranji M; Mirzaei E; Hosseini F; Nezafat N
Int Immunopharmacol; 2023 Dec; 125(Pt A):111062. PubMed ID: 37866317
[TBL] [Abstract][Full Text] [Related]
3. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
[TBL] [Abstract][Full Text] [Related]
4. Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity.
Xu L; Xiang J; Liu Y; Xu J; Luo Y; Feng L; Liu Z; Peng R
Nanoscale; 2016 Feb; 8(6):3785-95. PubMed ID: 26814441
[TBL] [Abstract][Full Text] [Related]
5. Graphene Oxides Decorated with Carnosine as an Adjuvant To Modulate Innate Immune and Improve Adaptive Immunity in Vivo.
Meng C; Zhi X; Li C; Li C; Chen Z; Qiu X; Ding C; Ma L; Lu H; Chen D; Liu G; Cui D
ACS Nano; 2016 Feb; 10(2):2203-13. PubMed ID: 26766427
[TBL] [Abstract][Full Text] [Related]
6. Lentinan-functionalized graphene oxide hydrogel as a sustained antigen delivery system for vaccines.
Jiao L; Wang Z; Song Z; Zhang T; Yu L; Yu R; Gao Q; Peng S; Jin H; Wang D; Liu Z
Int J Biol Macromol; 2023 Dec; 253(Pt 1):126629. PubMed ID: 37657564
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
8. Lentinan-Functionalized Graphene Oxide Is an Effective Antigen Delivery System That Modulates Innate Immunity and Improves Adaptive Immunity.
Liu Z; He J; Zhu T; Hu C; Bo R; Wusiman A; Hu Y; Wang D
ACS Appl Mater Interfaces; 2020 Sep; 12(35):39014-39023. PubMed ID: 32805921
[TBL] [Abstract][Full Text] [Related]
9. In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives.
Zeng Y; Zou F; Xia N; Li S
Expert Rev Vaccines; 2023; 22(1):681-695. PubMed ID: 37496496
[TBL] [Abstract][Full Text] [Related]
10. Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery.
Wang ZB; Xu J
Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32183209
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine.
Bai Q; Wang Z; An Y; Tian J; Li Z; Yang Y; Dong Y; Chen M; Liu T
Vaccine; 2022 Dec; 40(52):7613-7621. PubMed ID: 36371365
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
13. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
[TBL] [Abstract][Full Text] [Related]
14. An overview of biodegradable nanomaterials and applications in vaccines.
Yan X; Zhou M; Yu S; Jin Z; Zhao K
Vaccine; 2020 Jan; 38(5):1096-1104. PubMed ID: 31813649
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of new vaccine adjuvants].
Zeng Z; Wang H; Zhang Z; Yi Y
Sheng Wu Gong Cheng Xue Bao; 2021 Jan; 37(1):78-87. PubMed ID: 33501791
[TBL] [Abstract][Full Text] [Related]
16. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
17. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
18. Current adjuvants and new perspectives in vaccine formulation.
Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of vaccine adjuvants for infectious diseases.
Lee S; Nguyen MT
Immune Netw; 2015 Apr; 15(2):51-7. PubMed ID: 25922593
[TBL] [Abstract][Full Text] [Related]
20. Applications of Chitosan Derivatives as Adjuvant for Nanoparticles Based Vaccines.
Narayanan RR; Maanvizhi S
Infect Disord Drug Targets; 2023; 23(3):e220922209066. PubMed ID: 36154588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
